Article
STAT3 And PD-L1 Are Negatively Regulated By ATM And Impact On The Prognosis Of Triple Negative Breast Cancer Patients With Low ATM Expression
2022-02-15
Abstract excerpt
<title>Abstract</title> <p><bold>Introduction:</bold> Triple negative breast cancer (TNBC) is known for its aggressive behaviors and lacking of effective treatment. Programmed cell death ligand-1 (PD-L1) inhibitor has just been approved for using in the management of advanced TNBC. To accurately screen TNBC sensitive to anti-PD-L1 treatment and to explore the feasibility of the ataxia-telangiectasia mutation prot...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d485e944-ce9c-5459-906f-4becb7cd3561
- DOI
- 10.21203/rs.3.rs-1345095/v1
